搜尋結果
2021年4月13日 · The crypto miner is "ridiculously" overvalued, it says. Shares of Riot Blockchain ( RIOT -1.47%) continued to climb a day after it provided investors with a Bitcoin ( BTC 2.88%) mining update ...
- Rich Duprey
- What Happened
- So What
- Now What
A well-regarded investor best known for going short is out with some bullish commentary on ContextLogic (WISH-3.29%), calling the e-commerce stock the "most asymmetrical opportunity" on his radar. Shares jumped higher as a result, trading up as much as 67.2% in the minutes after the comments were released.
ContextLogic runs Wish.com, a site that attempts to match consumers to deals on products they have expressed an interest in. The site has been around for more than a decade and generated more than $2 billion in sales last year but has largely been an also-ran among e-commercesites. Citron Research, a Wall Street firm that is best known for going sh...
Investors should note there are a lot of "ifs" in this bull case. Most notably, Citron is hoping that the Temu ads have a real impact on consumer behavior and bring new business to Wish. This is still a relatively small player by e-commerce standards, worth just $650 million even after the Monday spike, and will likely be a volatile stock in the da...
- Lou Whiteman
其他人也問了
Will Citron Research tell investors what stocks to buy?
Is Citron Research a third-party?
What did Citron Research say about Inovio?
Should you buy Citron (Citron) after the Monday Spike?
2020年3月10日 · $263M. Today's Change. (-2.02%) -$0.21. Current Price. $10.16. Price as of April 24, 2024, 4:00 p.m. ET. The activist short-seller is highly skeptical about the biotech's claims regarding its...
2021年1月29日 · But Citron Research founder Andrew Left says that after losing 100% of his short position in the video game retailer, he's giving up telling investors what stocks to bet against. From now on, his...
- Rich Duprey
2020年6月9日 · In a tweet, Citron Research, run by short-seller Andrew Left, today revealed its skepticism about the stock's recent rise, stating that it sees shares of Nikola falling to $40 in the next few...
- Scott Levine
2020年3月14日 · However, Citron Research singled out Inovio on Monday, claiming that the biotech company should be investigated by the Securities and Exchange Commission (SEC) for some of these claims. Shares of...
2020年2月21日 · Current Price. $24.29. Price as of April 19, 2024, 4:00 p.m. ET. The company continues to coast on a positive note from Citron Research. What happened. Physics-based software maker and drug...
